Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 17/20 | 0.58 |
| ▸ | CA2 | P00918 | 17/20 | 0.58 |
| ▸ | CA9 | Q16790 | 17/20 | 0.58 |
| ▸ | CA1 | P00915 | 16/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 13/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5689104 | 0.98 | CA12 (0.56) | CA12CA2CA9CA1CA14 | |
| SCHEMBL18230 | 0.81 | CA12 (0.41) | CA12CA2CA9CA1CA14 | |
| Hydrochloric Acid SCHEMBL28658656 | 0.79 | CA12 (0.40) | CA12CA2CA9CA1CA14 | |
| SCHEMBL5700130 | 0.79 | CYP17A1 (0.42) | CA12CA2CA9CA1CA14 | |
| SCHEMBL2879049 | 0.79 | NAPRT (0.44) | CA12CA2CA9CA1CA14 | |
| Hydrochloric Acid SCHEMBL7862325 | 0.78 | NAPRT (0.42) | CA12CA2CA9CA1CA14 | |
| SCHEMBL24668619 | 0.77 | CA2 (0.60) | CA12CA2CA9CA1CA14 | |
| SCHEMBL394384 | 0.77 | CA12 (0.60) | CA12CA2CA9CA1CA14 | |
| SCHEMBL30727320 | 0.76 | CYP17A1 (0.40) | CA12CA2CA9CA1CA14 | |
| SCHEMBL27327312 | 0.76 | CYP17A1 (0.40) | CA12CA2CA9CA1CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116240548-B | Etching solution for selectively etching AlCu layer relative to laminated metal and preparation method thereof | 湖北兴福电子材料股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-118955366-A | Tola plug Rice production method | 湖南赛隆药业有限公司 | 2024-11-15 | — | — | CN | claimed |
| WO-2024115549-A1 | ARYL- AND HETEROARYL-SULFONAMIDE DERIVATIVES AS CCR8 MODULATORS | IDORSIA PHARMACEUTICALS LTD (CH) | 2024-06-06 | — | — | WO | claimed |
| CN-116240548-A | Etching solution for selectively etching AlCu layer relative to laminated metal and preparation method thereof | 湖北兴福电子材料股份有限公司 | 2023-06-09 | — | — | CN | claimed |
| CN-113620868-A | Torasemide new impurity and preparation method thereof | 南京恒正药物研究院有限公司 | 2021-11-09 | — | — | CN | claimed |
| CN-102702089-B | Method for preparing high-purity torasemide and crystal form I thereof | LIANYUNGANG JARI PHARMACEUTICAL CO LTD | 2014-08-27 | — | — | CN | claimed |
| CN-102702089-A | Method for preparing high-purity torasemide and crystal form I thereof | LIANYUNGANG JARI PHARMACEUTICAL CO LTD | 2012-10-03 | — | — | CN | claimed |
| WO-2004089904-A2 | PREPARATION OF TORASEMIDE | TORCAN CHEMICAL LTD. (CA) | 2004-10-21 | — | — | WO | claimed |
| WO-2003097603-A1 | PROCESS FOR THE PREPARATION OF HIGHLY PURE TORSEMIDE | FINETECH LABORATORIES LTD. (IL) | 2003-11-27 | — | — | WO | claimed |
| US-20260078092-A1 | SULFONYL CARBOXAMIDE COMPOUND, THEIR DERIVATIVES, AND USES THEREOF | SHAH SALIM (US) | 2026-03-19 | — | — | US | disclosed |
| EP-3541804-B1 | CYCLOALKYL SUBSTITUTED TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC (US) | 2025-01-22 | — | — | EP | disclosed |
| CN-116240548-B | Etching solution for selectively etching AlCu layer relative to laminated metal and preparation method thereof | 湖北兴福电子材料股份有限公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-119241588-A | Sulfonamide compound for treatment and enantiomer thereof, preparation method and application | 华创合成制药股份有限公司 | 2025-01-03 | — | — | CN | disclosed |
| EP-3541802-B1 | ALKYL SUBSTITUTED TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC (US) | 2025-01-01 | — | — | EP | disclosed |
| US-6310214-B1 | FROM HYDROXYPYRIDINESULPHONIC ACIDS COMPRISING PASSING CHLORINE GAS INTO A MIXTURE OF A HYDROXYPYRIDINESULPHONIC ACID AND OF PHOSPHORUS TRICHLORIDE; HEATING; DISTILLATION | RUETGERS ORGANICS GMBH (DE) | 2001-10-30 | — | — | US | disclosed |
| EP-1048654-A2 | Process for the preparation of chloropyridine sulfonyl chloride | Rütgers Organics GmbH (DE) | 2000-11-02 | — | — | EP | disclosed |
| WO-2000063177-A1 | METHOD OF PRODUCING CHLOROPYRIDINE SULFONIC ACID CHLORIDES | RÜTGERS ORGANICS GMBH (DE) | 2000-10-26 | — | — | WO | disclosed |
| EP-0618209-B1 | Pyridothiadiazines, processes for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1998-12-23 | — | — | EP | disclosed |
| US-5459138-A | Dysfunctions of glutamatergic neurotransmission associated with learning and memory | ADIR ET COMPAGNIE (FR) | 1995-10-17 | — | — | US | disclosed |
| EP-0618209-A1 | Pyridothiadiazines, processes for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1994-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078092-A1 | SULFONYL CARBOXAMIDE COMPOUND, THEIR DERIVATIVES, AND USES THEREOF | ATP2A1, ATP2A2, ATP2A3 | CA12 1517/4885CA2 27/4885CA9 802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.